CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
$5.86 0.09 (1.5598%)
Analysed CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) News Sources
Cumberland Pharmaceuticals jumps on $100M Apotex transaction
23-04-2026
advfn.com
Cumberland to sell drug portfolio to Apotex for $100m
24-04-2026
hospitalmanagement.net
Broadwind And 2 Promising Penny Stocks For Your Investment Radar
24-04-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
28-04-2026
yahoo.com
Cumberland Pharmaceuticals (CPIX) Integrates Commercial Business with Apotex
05-05-2026
yahoo.com
CUMBERLAND PHARMACEUTICALS REPORTS Q1 2026 FINANCIAL RESULTS & COMPANY UPDATE
05-05-2026
yahoo.com
Cumberland Pharmaceuticals Q1 Earnings Call Highlights
05-05-2026
marketbeat.com
Cumberland Pharmaceuticals Inc. Q1 2026 Earnings Call Summary
06-05-2026
moby.co
Cumberland Posts Loss in Q1 Amid $100M Apotex Deal Plan
06-05-2026
yahoo.com
Top Analyst Reports for Alphabet, Apple & Micron Technology
27-05-2026
yahoo.com
What is the current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The current price of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is $5.86.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is $0.09.
CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) since the previous trading day is 1.5598%.
What is the most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent average sentiment score for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is 75 out of 100.
What is the most recent average sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)?
The most recent sentiment for CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ) is .
SEC-8K** Filing Available For CUMBERLAND PHARMACEUTICALS (CPIX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.